The WHO's move came nearly three weeks after India objected to the B.1.617 mutant of the novel coronavirus being termed an 'Indian Variant' in media reports with the Union Health Ministry pointing out that the UN's top health organ has not used the word 'Indian' for this strain in its document.
'There is nothing to worry about. This is a variant of coronavirus and its treatment is possible'
Bharat Biotech on Wednesday said a study has demonstrated that a booster dose of Covaxin has a neutralising effect on the Omicron and Delta variants of COVID-19.
While virologists say theoretically the vaccine that works on Delta should work on the Delta Plus variant as well, more research is needed.
Omicron is a 'deviant' from the COVID-19 pandemic progression script and so it must be postulated that two pandemics are going on side by side, one by the Delta and close relatives and the other by the latest variant of concern, said noted virologist Dr T Jacob John.
The B.1.617 variant was first detected in India and was divided in three lineages -- B.1.617.1, B.1.617.2 and B.1.617.3.
"This antibody is both highly neutralising (meaning it works very well at low concentrations) and broadly neutralising (meaning it works against all variants)," said Michael S Diamond, a professor at Washington University School of Medicine in St Louis, US.
'We have to take all preparations because the third wave is likely to start from September-October onward'
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances